Can ER/PR-positive breast cancer treatment cause joint pain?

Hi,

Welcome to icliniq.com.

I can understand your concern.

Thank you for sharing your mother's treatment history. She is doing well to have completed surgery and radiation for ER/PR-positive, HER2-negative breast cancer, and it is excellent that she is on Letrozole, a standard aromatase inhibitor (AI) for postmenopausal women. Joint pain (arthralgia) and hot flashes are among the most common side effects of aromatase inhibitors like Letrozole.

These occur because AIs drastically lower estrogen levels, which can affect joint lubrication, thermoregulation, and overall musculoskeletal comfort. The symptoms can fluctuate but are generally manageable with exercise, especially stretching, resistance training, and omega-3 supplements. In some cases, switching to another AI (e.g., Exemestane) or using low-dose Duloxetine or Gabapentin may help with joint or vasomotor symptoms.

Hormonal therapy with aromatase inhibitors like Letrozole is typically continued for five years, but depending on the patient’s recurrence risk, tolerance, and tumor characteristics, such as lymph node involvement, tumor size, or high-grade features, it may be extended to seven to 10 years.

During treatment, estrogen levels are not routinely monitored, as Letrozole effectively suppresses estrogen to postmenopausal levels; instead, clinicians focus on clinical response, side effects, and adherence. One common concern is bone loss, since aromatase inhibitors can accelerate it. If bone density is slightly low, the recommended strategy includes 1000 to 1200 mg of calcium per day, 800 to 1000 IU of vitamin D, and a DEXA (dual energy x-ray absorptiometry) scan every one to two years.

For patients with a T-score below 2.0 or a high fracture risk, bisphosphonates such as Alendronate or intravenous Zoledronic acid may be started. Some oncologists even use yearly Zoledronic acid to preserve bone and possibly reduce recurrence. While weight gain on Letrozole is common, it does not directly increase recurrence risk; however, obesity is associated with higher estrogen levels from fat tissue, insulin resistance, and inflammation, which could influence long-term outcomes.

Therefore, maintaining a healthy weight through a balanced diet and exercise is strongly encouraged. In summary, joint pain and hot flashes are expected but manageable side effects; hormonal therapy generally lasts five to 10 years; hormone levels are not tracked during treatment; calcium and vitamin D supplementation are essential for bone health; and weight gain should be proactively addressed to support overall wellness.

I hope this information will help you.

Thank you.